Markets
Wegovy...
Wegovy injection (Steve Christo/Getty Images)

Hims & Hers falls after Novo Nordisk launches discounted Wegovy for uninsured

The reduced price for Wegovy is still roughly double what compounded versions cost.

J. Edward Moreno

Hims & Hers shares fell and Novo Nordisk shares rose after the drugmaker announced Wednesday morning that it launched a telehealth platform, NovoCare, designed to give uninsured patients access to Wegovy, its blockbuster weight-loss drug.

Novo Nordisk, the Danish drugmaker that makes popular GLP-1 weight-loss drugs, said NovoCare will allow patients without insurance to access their drugs directly at almost a third of the cost it typically charges insurers. This comes after the Food and Drug Administration declared on February 21 that the shortage of semaglutide, the active ingredient in Wegovy and Ozempic, is over, ending the allowance for copycat pharmacies like Hims & Hers to sell exact copies.

Hims & Hers has said its game plan moving forward is to sell Novo Nordisk’s older, less effective GLP-1 drugs and oral medications.

NovoCare will offer Wegovy for $499 a month for patients without insurance. While that is more affordable than the upward of $1,300 Novo Nordisk charges patients with insurance, its still more than double what the compounded versions cost.

That said, Wegovy comes in individual pens that are prefilled with the patient’s dose. Compounding pharmacies typically send a vial and the patient is responsible for administering the dose. That makes Wegovy (and similar GLP-1 drugs) more costly to produce than compounded versions.

Screenshot 2025-03-05 at 9.51.19 AM
Sherwood News

Eli Lilly, which makes competing GLP-1 drugs, announced a similar platform dubbed Lilly Direct that offers its drugs to insured patients at similar price points as NovoCare. (Hims & Hers has never sold copycat versions of Eli Lillys drugs, though other compounding pharmacies have.)

Compounding pharmacies have been a pain in the side of Novo Nordisk and Eli Lilly, chipping away at the edges of their market share for GLP-1 drugs. The pharmaceutical giants have launched ad campaigns questioning the safety of compounded drugs.

More Markets

See all Markets
markets
Luke Kawa

Trump Media jumps after announcing plans to distribute digital tokens to shareholders

Trump Media & Technology Group is jumping in premarket trading after the owner of Truth Social announced plans to distribute a digital token to shareholders in partnership with Crypto.com (which is also its partner in the event contracts space).

Shareholders will receive one token per share owned, according to the press release, which can give the holder access to “various rewards” that “may include benefits or discounts tied to Trump Media products.”

This move is a little closer to home for Trump Media, which has effectively been a digital asset treasury, compared to its recent merger with fusion energy company TAE Technologies, which will radically transform the entity.

markets
Luke Kawa

Nvidia, TSMC rise as the world’s most valuable company reportedly asks for more chips to meet Chinese demand

Nvidia and TSMC are modestly higher in premarket trading Wednesday after Reuters reported that the chip designer asked the Taiwanese chip manufacturing giant to boost production of its H200 AI chips.

Earlier this month, US President Donald Trump said that Nvidia would be able to ship the best-performing processors from its Hopper generation to China, with 25% of the proceeds going to the US government. Per the report, Chinese companies have already placed orders for more than 2 million of these chips in 2026, roughly triple the 700,000 in inventory that Nvidia has in reserve. Reuters added that Nvidia is planning on selling these chips at around $27,000 apiece, which would amount to a more than $54 billion boost in revenues if it’s able to realize all this reported demand. The ability to do so will also depend on Chinese regulators green-lighting purchases. The chip designer’s success in 2025 has come despite being effectively shut out of the Chinese AI market for the year.

The outlet previously reported that Nvidia plans to begin sending these GPUs to China before the Lunar New Year holiday (which starts on February 17, 2026), and that Chinese companies are eagerly awaiting the opportunity to get their hands on these powerful chips.

During Nvidia’s Q3 conference call, which came prior to the Trump announcement, CEO Jensen Huang expressed confidence in his ability to meet demand for the company’s GPUs going forward, saying, “In many cases, we’ve secured a lot of supply for ourselves, because obviously, they’re working with the largest company in the world in doing so.”

Huang’s relationship with critical supply chain partner TSMC appears to benefit from a personal touch: during his November visit to Taiwan, he met with the chipmaker’s CEO, CC Wei, as well as other execs over hot pot, and called TSMC “the pride of the world” the next day.

markets
Luke Kawa

Nike rises after CEO Elliott Hill purchases $1 million in company stock

Nike is sprinting to the finish line in 2025, up more than 2% in premarket trading after a filing after the close on Tuesday showed that CEO Elliott Hill purchased a little over $1 million in company stock on December 29.

The news comes on the heels of last week’s revelation that Apple CEO and board member Tim Cook bought nearly $3 million in Nike stock.

Hill returned to the company to replace former CEO John Donahoe in October 2024. This is Hill’s only open market purchase of Nike stock during his tenure atop the company.

Shares of the sports apparel maker are still down about 17% year to date.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.